Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Abdelrahman Fouda and Esraa Shosha.

 
Connection Strength
  
 
 
5.417
  
  1. Shosha E, Fouda AY. A metabolic switch in retinal angiogenesis: Histone deacetylase 3. Neural Regen Res. 2026 Mar 14.
    View in: PubMed
    Score: 0.979
  2. Shosha E, Chauhan MZ, Muayad J, Sallam AB, Fouda AY. Systemic Lactate Dehydrogenase Levels as a Predictor of Progression from Non-Proliferative to Proliferative Diabetic Retinopathy. J Clin Med. 2025 Dec 08; 14(24).
    View in: PubMed
    Score: 0.962
  3. Fouda AY, Shosha E. Efferocytosis and retinal clean-up: role of histone deacetylase 3 in ischemic retinopathy. Neural Regen Res. 2025 Feb 24.
    View in: PubMed
    Score: 0.911
  4. Shosha E, Shahror RA, Morris CA, Xu Z, Lucas R, McGee-Lawrence ME, Rusch NJ, Caldwell RB, Fouda AY. The arginase 1/ornithine decarboxylase pathway suppresses HDAC3 to ameliorate the myeloid cell inflammatory response: implications for retinal ischemic injury. Cell Death Dis. 2023 09 21; 14(9):621.
    View in: PubMed
    Score: 0.825
  5. Shahror RA, Zaman B, Chuesiang P, Wild M, Shosha E, Leung YK, Mu S, Rusch NJ, Fouda AY. CD5L promotes efferocytosis and resolution of retinal ischemic injury. Cell Death Dis. 2026 Apr 20; 17(1).
    View in: PubMed
    Score: 0.247
  6. Mitchell CD, Morris CA, Wild M, Cunningham A, Chuesiang P, Mohammed AA, Nagalo BM, Rusch NJ, Fouda AY, Shosha E. HDAC3 mediates retinal endothelial cell metabolic reprogramming and angiogenesis. Acta Pharmacol Sin. 2026 Apr; 47(4):1058-1069.
    View in: PubMed
    Score: 0.237
  7. Morris CA, Sadek MA, Modi P, Abdelnaem S, Rusch NJ, Shosha E, Fouda AY. The role of efferocytosis in ischemic stroke and insights from retinopathy. Trends Neurosci. 2025 Aug; 48(8):624-639.
    View in: PubMed
    Score: 0.234
  8. Shahror RA, Shosha E, Ji MH, Morris CA, Wild M, Zaman B, Mitchell CD, Tetelbom P, Leung YK, Phillips PH, Sallam AA, Fouda AY. Proteomic Analysis of Aqueous Humor in Central Retinal Artery Occlusion: Unveiling Novel Insights Into Disease Pathophysiology. Transl Vis Sci Technol. 2024 Aug 01; 13(8):30.
    View in: PubMed
    Score: 0.219
  9. Shahror RA, Shosha E, Morris C, Wild M, Mu S, Csanyi G, Boerma M, Rusch NJ, Fouda AY. Deletion of myeloid HDAC3 promotes efferocytosis to ameliorate retinal ischemic injury. J Neuroinflammation. 2024 Jul 12; 21(1):170.
    View in: PubMed
    Score: 0.218
  10. Shahror RA, Morris CA, Mohammed AA, Wild M, Zaman B, Mitchell CD, Phillips PH, Rusch NJ, Shosha E, Fouda AY. Role of myeloid cells in ischemic retinopathies: recent advances and unanswered questions. J Neuroinflammation. 2024 Mar 07; 21(1):65.
    View in: PubMed
    Score: 0.213
  11. Fouda AY, Xu Z, Suwanpradid J, Rojas M, Shosha E, Lemtalsi T, Patel C, Xing J, Zaidi SA, Zhi W, Stansfield BK, Cheng PN, Narayanan SP, Caldwell RW, Caldwell RB. Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair. Cell Death Dis. 2022 08 29; 13(8):745.
    View in: PubMed
    Score: 0.192
  12. Fouda AY, Eldahshan W, Xu Z, Lemtalsi T, Shosha E, Zaidi SA, Abdelrahman AA, Cheng PN, Narayanan SP, Caldwell RW, Caldwell RB. Preclinical investigation of Pegylated arginase 1 as a treatment for retina and brain injury. Exp Neurol. 2022 02; 348:113923.
    View in: PubMed
    Score: 0.181
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.